Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SUTRO-BIOPHARMA-INC-46353309/news/Sutro-Biopharma-Announces-Presentation-of-Data-for-Luveltamab-Tazevibulin-from-the-Phase-1-Dose-Expa-45122150/?utm_source=whatsapp&utm_medium=social&utm_campaign=share